Literature DB >> 15970672

Effector proteins for methylated histones: an expanding family.

Jeremy A Daniel1, Marilyn G Pray-Grant, Patrick A Grant.   

Abstract

Methylation of histone lysine residues in eukaryotic chromatin has been an exciting area of research ever since the first histone methyltransferase enzyme, Suv39h, was found to methylate lysine 9 of histone H3 in 2000. Only a year later, the HP1 chromodomain polypeptide was identified as a recognition module for this histone modification. Similar to bromodomain-containing proteins that recognize histone acetylation sites and subsequently stabilize large complexes to chromatin, effector proteins can also be recruited and stabilized by histone methylation. Although histone acetylation generally correlates with active transcription, histone methylation is associated with both the activation and silencing of transcription, depending on which lysine residue is modified. The list of proteins that may in fact directly associate with specific methylated histone lysines is expanding. Since the finding of HP1, many additional proteins have been shown to bind methylated histone residues. For instance, Polycomb, Chd1, 53BP1, and Crb2/Rad9 proteins all associate with methylated chromatin in a unique manner governed by their respective recognition motifs. Here we highlight recent data on the recognition specificity and biological significance of proteins that associate with methylated histone lysines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970672     DOI: 10.4161/cc.4.7.1824

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  47 in total

Review 1.  Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?

Authors:  Mariana D Plazas-Mayorca; Kent E Vrana
Journal:  J Proteome Res       Date:  2010-09-09       Impact factor: 4.466

2.  Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation.

Authors:  María J Barrero; Sohail Malik
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

3.  Identifying novel proteins recognizing histone modifications using peptide pull-down assay.

Authors:  Joanna Wysocka
Journal:  Methods       Date:  2006-12       Impact factor: 3.608

Review 4.  Multi-tasking on chromatin with the SAGA coactivator complexes.

Authors:  Jeremy A Daniel; Patrick A Grant
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression.

Authors:  Lisandra E West; Siddhartha Roy; Karin Lachmi-Weiner; Ryo Hayashi; Xiaobing Shi; Ettore Appella; Tatiana G Kutateladze; Or Gozani
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 6.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

Review 7.  Protein arginine methyltransferases: from unicellular eukaryotes to humans.

Authors:  François Bachand
Journal:  Eukaryot Cell       Date:  2007-04-27

Review 8.  The SAGA continues: expanding the cellular role of a transcriptional co-activator complex.

Authors:  S P Baker; P A Grant
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Molecular basis of the interaction of Saccharomyces cerevisiae Eaf3 chromo domain with methylated H3K36.

Authors:  Bingfa Sun; Jing Hong; Peng Zhang; Xianchi Dong; Xu Shen; Donghai Lin; Jianping Ding
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

Review 10.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.